September 28, 2015

Aurobindo’s latest generic is of Pfizer’s Lopid, which treats high cholesterol alongside diet and exercise.

September 28, 2015

Mylan’s latest generic, recently approved by the Food and Drug Administration, is intended to treat schizophrenia and schizoaffective disorder.

September 25, 2015

In the latest on the Mylan bid for Perrigo, Mylan on Thursday released a statement about the Perrigo lawsuit filed in Israel on Thursday.

September 25, 2015

Health benefit plan cost trend rates for 2016 will increase for most medical plan options and increase substantially for prescription drug coverage to double-digit rates, according to forecasts compiled in the 2016 Segal Health Plan Cost Trend Survey, Segal’s nineteenth annual survey of health plan cost trends. Trend is the forecast of annual gross per capita claims cost increases.

September 24, 2015

Aurobindo Pharma on Thursday announced that the Food and Drug Administration had approved its generic of AstraZeneca’s Prilosec (omeprazole) delayed-release capsules. 

September 24, 2015

The discount program’s website provides members online tools for finding participating pharmacies, as well as drug prices and availability. 

September 23, 2015

The launch comes after Camber’s parent company, Hetero Labs received final approval from the Food and Drug Administration.

September 23, 2015

CVS/pharmacy has also renewed its Medication Disposal for Safer Communities Program.

September 23, 2015

The pharmacy will be located in the NEOMED Education and Wellness Center in Ohio. 

September 22, 2015

Impax Laboratories announced Tuesday that the Food and Drug Administration had approved its generic of Valeant’s Testred (methyltestosterone) capsules.

September 22, 2015

Democratic presidential candidate Hillary Clinton on Tuesday announced plans that would reduce out-of-pocket drug costs for many American consumers should she be elected President of the United States. 

September 22, 2015

Perrigo received Food and Drug Administration approval for a therapeutic equivalent to Valeant’s BenzaClin acne treatment. 

September 22, 2015

The campaign includes an ambassador program where Rite Aid coordinators will plan and implement onsite workplace flu clinics staffed by certified immunizing Rite Aid pharmacists. 

September 21, 2015

In July, Stichting Preferred Shares Mylan exercised its full call option on over 488,000,000 preferred shares in Mylan — a move aimed at fending off Teva’s since abandoned attempt at acquiring the pharmaceutical company.

September 21, 2015

This is Impax’s first drug to be approved following its Sept. 4 resolution of issues outlined by the FDA in a warning letter to the company.

September 21, 2015

A new CVS Health Research Insitute study, done in partnership with Brigham and Women’s Hospital, is offering insight into the reasons many patients don’t adhere to their medication regimen.

September 18, 2015

The Centers for Disease Control and prevention this week announced that a new draft guideline for prescribing opioids to patients with chronic pain was in the works. 

September 18, 2015

Overall, CDC estimates that 47% of the U.S. population age 6 months and older was vaccinated during the 2014-2015 season, similar to the 2013-2014 season and up from an estimated 41% five years ago.

September 18, 2015

McKesson on Friday bought the pharmaceutical distribution division of Ireland's UDG Healthcare in a cash transaction valued at $466.5 million. 

September 18, 2015

Mylan on Friday launched its generic version of Lescol XL (fluvastatin sodium) extended-release tablets.

September 17, 2015

Camber Pharmaceuticals announced this week that it had launched generics of GlaxoSmithKline’s Valtrex (valacyclovir) and Eisai’s Aricept (donepezil).

September 17, 2015

Aurobindo Pharma’s received approval from the Food and Drug Administration this week for its generic of Roxane Laboratories’ Dolophine (methadone HCL) tablets. 

September 17, 2015
The company’s president, CEO and chairman Joseph Papa has issued a letter to shareholders recommending against tendering their shares to Mylan.